MedTech Dive April 30, 2024
Endomagnetics, which makes guidance technology for breast cancer surgery, brought in about $35 million in revenue last year.
Dive Brief:
- Hologic plans to acquire Endomagnetics, which makes technology for breast cancer surgery, for about $310 million.
- Cambridge, U.K.-based Endomagnetics develops and sells technologies to mark tissue ahead of a surgery and for lymphatic tracing, which is used to identify areas where cancer may have spread outside of a tumor.
- Erik Anderson, Hologic’s president of breast and skeletal health solutions, said in a Monday statement that the acquisition would complement the company’s existing breast surgery portfolio. Marlborough, Massachusetts-based Hologic makes mammography systems, breast biopsy systems and markers.
Dive Insight:
Endomagnetics was founded in 2007 and offers three...
Today's Sponsors
Today's Sponsor